rs529326848

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001122630.2(CDKN1C):​c.567A>G​(p.Pro189Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0088 in 741,352 control chromosomes in the GnomAD database, including 206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P189P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.036 ( 162 hom., cov: 31)
Exomes 𝑓: 0.0042 ( 44 hom. )

Consequence

CDKN1C
NM_001122630.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -8.37

Publications

4 publications found
Variant links:
Genes affected
CDKN1C (HGNC:1786): (cyclin dependent kinase inhibitor 1C) This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
CDKN1C Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • IMAGe syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, G2P, Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Beckwith-Wiedemann syndrome due to CDKN1C mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intrauterine growth restriction-short stature-early adult-onset diabetes syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Silver-Russell syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-2884890-T-C is Benign according to our data. Variant chr11-2884890-T-C is described in ClinVar as Benign. ClinVar VariationId is 236964.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.37 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.112 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1CNM_001122630.2 linkc.567A>G p.Pro189Pro synonymous_variant Exon 2 of 4 ENST00000440480.8 NP_001116102.1 P49918-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1CENST00000440480.8 linkc.567A>G p.Pro189Pro synonymous_variant Exon 2 of 4 1 NM_001122630.2 ENSP00000411257.2 P49918-2

Frequencies

GnomAD3 genomes
AF:
0.0360
AC:
3880
AN:
107736
Hom.:
161
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.0289
Gnomad AMR
AF:
0.0161
Gnomad ASJ
AF:
0.00465
Gnomad EAS
AF:
0.00111
Gnomad SAS
AF:
0.00924
Gnomad FIN
AF:
0.00135
Gnomad MID
AF:
0.0400
Gnomad NFE
AF:
0.00320
Gnomad OTH
AF:
0.0211
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
22
AF XY:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00416
AC:
2637
AN:
633540
Hom.:
44
Cov.:
9
AF XY:
0.00393
AC XY:
1172
AN XY:
298128
show subpopulations
African (AFR)
AF:
0.0897
AC:
1043
AN:
11630
American (AMR)
AF:
0.00712
AC:
14
AN:
1966
Ashkenazi Jewish (ASJ)
AF:
0.00385
AC:
19
AN:
4930
East Asian (EAS)
AF:
0.00184
AC:
8
AN:
4346
South Asian (SAS)
AF:
0.00321
AC:
41
AN:
12778
European-Finnish (FIN)
AF:
0.000664
AC:
3
AN:
4518
Middle Eastern (MID)
AF:
0.00502
AC:
7
AN:
1394
European-Non Finnish (NFE)
AF:
0.00236
AC:
1345
AN:
569998
Other (OTH)
AF:
0.00714
AC:
157
AN:
21980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
100
200
299
399
499
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0361
AC:
3888
AN:
107812
Hom.:
162
Cov.:
31
AF XY:
0.0345
AC XY:
1829
AN XY:
53056
show subpopulations
African (AFR)
AF:
0.115
AC:
3437
AN:
29760
American (AMR)
AF:
0.0162
AC:
186
AN:
11492
Ashkenazi Jewish (ASJ)
AF:
0.00465
AC:
12
AN:
2582
East Asian (EAS)
AF:
0.00112
AC:
4
AN:
3576
South Asian (SAS)
AF:
0.00955
AC:
31
AN:
3246
European-Finnish (FIN)
AF:
0.00135
AC:
8
AN:
5928
Middle Eastern (MID)
AF:
0.0347
AC:
5
AN:
144
European-Non Finnish (NFE)
AF:
0.00320
AC:
157
AN:
49022
Other (OTH)
AF:
0.0210
AC:
31
AN:
1474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
171
342
512
683
854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 07, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 17, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Beckwith-Wiedemann syndrome Benign:2
Feb 24, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Beckwith-Wiedemann syndrome;C1846009:IMAGe syndrome Benign:1
Jan 12, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
7.0
DANN
Benign
0.46
PhyloP100
-8.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs529326848; hg19: chr11-2906120; API